Ruben Pio

8PUBLICATIONS
84CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 03, 2026
Complement-driven NETosis mediates immunotherapy resistance in STK11-mutant lung adenocarcinoma.

|Apr 28, 2026
Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance.

|Dec 12, 2024
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response.

Yaiza Senent, Ana Remírez, David Repáraz

|Nov 03, 2024
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1.

Francisco Exposito, Miriam Redrado, Diego Serrano

|Feb 22, 2022
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.

Borja Ruiz-Fernández de Córdoba, Haritz Moreno, Karmele Valencia

|Feb 05, 2022
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade.

Daniel Ajona, Sergio Ortiz-Espinosa, Teresa Lozano

Pageof 2

Frequent Collaborators

4 joint publications

Daniel Ajona

2 joint publications

Ana Remírez

2 joint publications

Marta Larrayoz

2 joint publications

Ignacio Melero